Liberty All-Star Growth Fund's Investment Insights Shared
Liberty All-Star Growth Fund, Inc. Monthly Update
This article provides a comprehensive overview of the Liberty All-Star Growth Fund, Inc. (NYSE: ASG) and its recent performance. Each month, the Fund's management team highlights important developments, investment strategies, and top holdings.
Investment Approach
Liberty All-Star Growth Fund employs an all-cap growth investment strategy. The Fund utilizes a unique approach by combining the expertise of three distinct growth investment managers. These managers focus on small-, mid-, and large-cap stocks and are rigorously monitored by the Fund’s Investment Advisor. This multifaceted strategy allows for diversified investment opportunities, catering to various market conditions.
Investment Managers
The management of the Fund involves the collaboration of experienced firms, each specializing in a specific capitalization focus. The Investment Managers include:
- Weatherbie Capital, LLC - Specializing in Small-Cap Growth
- Congress Asset Management Company, LLP - Focusing on Mid-Cap Growth
- Westfield Capital Management Company, L.P. - Concentrating on Large-Cap Growth
Top Holdings Overview
At the end of September 2024, the Liberty All-Star Growth Fund had a diverse portfolio. The top 20 holdings collectively represent a significant portion of the equity portfolio, demonstrating the Fund's strategic allocation towards high-growth companies. Here are some of the leading holdings:
- NVIDIA Corp. - 3.6%
- Apple, Inc. - 3.2%
- Microsoft Corp. - 3.0%
- Amazon.com, Inc. - 2.8%
- Alphabet, Inc. - 2.1%
- Meta Platforms, Inc. - 2.1%
- SPS Commerce, Inc. - 2.0%
- Natera, Inc. - 2.0%
- FirstService Corp. - 2.0%
- Casella Waste Systems, Inc. - 1.8%
- Hamilton Lane, Inc. - 1.7%
- StepStone Group, Inc. - 1.7%
- Glaukos Corp. - 1.6%
- Tandem Diabetes Care, Inc. - 1.4%
- Visa, Inc. - 1.3%
- TransDigm Group, Inc. - 1.3%
- Ollie's Bargain Outlet Holdings, Inc. - 1.3%
- Booz Allen Hamilton Holding Corp. - 1.1%
- Casey's General Stores, Inc. - 1.1%
- Brown & Brown, Inc. - 1.0%
Monthly Performance Highlights
The performance metrics for September 2024 reflected the Fund's resilience in changing markets:
- Beginning of Month NAV: $5.96
- End of Month NAV: $6.03
- Performance for the Month: 1.17%
- Year-to-Date Performance: 11.90%
- Market Price as of Month-End: $5.48
The data illustrates not only the performance growth over the month but also a steady year-to-date yield. Understanding these metrics is crucial for investors evaluating the Fund's stability and growth trajectory.
Portfolio Overview and Sector Allocation
The investment sectored distribution is key to the Fund's growth narrative. As of the latest assessment:
- Information Technology: 29.7%
- Health Care: 18.5%
- Industrials: 17.2%
- Financials: 11.3%
- Consumer Discretionary: 9.7%
- Communication Services: 5.7%
- Consumer Staples: 3.9%
- Real Estate: 2.4%
- Materials: 0.8%
- Energy: 0.8%
This distribution indicates a significant focus on technology, illustrating the management's belief in the sector’s potential for growth and innovation.
New Holdings and Liquidations
During the month of September, the Fund made several adjustments in its holdings with the introduction of:
- American Eagle Outfitters, Inc.
- AptarGroup, Inc.
- Oracle Corp.
Conversely, certain positions were liquidated, notably:
- Entegris, Inc.
- Nevro Corp.
These changes reflect the dynamic approach Liberty All-Star Growth Fund takes to adapt to market conditions, emphasizing the significance of timely decisions in maximizing investor returns.
Conclusion
In summary, the Liberty All-Star Growth Fund, Inc. continues to demonstrate adaptability and strategic foresight in managing investments. The integration of various growth strategies, a diversified portfolio, and a strong focus on high-performing sectors are all essential components that underpin its ongoing success.
Frequently Asked Questions
1. What is the primary investment strategy of Liberty All-Star Growth Fund?
The Fund employs an all-cap growth strategy, utilizing multiple investment managers to focus on varying capitalizations.
2. How does the Fund's performance relate to market conditions?
The performance fluctuates with market changes, reflecting the adaptive strategies employed in asset management.
3. What are the top sectors represented in the Fund's portfolio?
The top sectors include Information Technology, Health Care, and Industrials, showcasing a focus on growth-oriented industries.
4. How often does the Fund update its holdings?
The Fund regularly reviews its holdings, making adjustments as necessary to optimize performance based on market conditions.
5. Where can I find more information about the Liberty All-Star Growth Fund?
For more details, interested parties can visit the Fund's official website.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.
Related Articles
- Chimera Investment Corporation Reveals Upcoming Financial Q3 Update
- Transforming $1,000 into $2,500: The Power of Investment
- Transforming $1,000 into $6,800: A CAPR Investment Journey
- Nurix Therapeutics' Fiscal Q3 2024 Financial Insights
- Hingham Institution for Savings Achieves Impressive Q3 Growth
- 89bio Unveils New Stock Options as Part of Growth Strategy
- A Deep Dive into Qifu Technology and Ibotta Investment Potential
- Evaluating Teradyne (NASDAQ: TER) as a Smart Investment Choice
- MYR Group Inc. to Network at Upcoming Investment Conference
- Clover Leaf Networks with Digital Ally for Business Growth
Recent Articles
- Harnessing Artificial Intelligence for Safer Aviation Practices
- Innovative Dual-Function Cup Sleeve Revolutionizes Beverage Use
- FDA's Innovative Approval for Groundbreaking Hemophilia Treatment
- Achieving Financial Goals with Vanguard S&P 500 ETF
- Celebrating Butchie: New York Islanders' Puppy with a Purpose
- Investigation Launches Into Toronto-Dominion Bank for Fraud
- Understanding the Current Market Position of Copart Stock
- Transformative Growth: CACI's Long-Term Investment Potential
- Transforming $1000 in Taiwan Semiconductor into Wealth Today
- Axos Financial: A Digital Banking Innovator with Strong Growth Potential
- Kinder Morgan's Future Looks Bright with Recent Upgrade
- Seagate Technology Thrives Amid Rising Demand for Storage Solutions
- Pfizer Gains FDA Approval for HYMPAVZI: A New Hope for Hemophilia Patients
- Ovintiv Announces Q3 2024 Results Conference Call Details
- The Unstoppable Rise of Netflix: A Stock to Watch
- Biogen's Earnings Potential: A Review Ahead of Next Report
- ICF International Inc. Reaches New Heights with Stock Surge
- CVS Health Achieves Milestone in Medicare Star Ratings Rating
- Allakos' Recent Trials Strengthen Hold Rating on ALLK Shares
- Corvus Pharmaceuticals Stock Hits Record High, Future Looks Bright
- Guiding IT Leaders in LLM Selection for Better Performance
- Barclays Maintains Positive Outlook for Sarepta Therapeutics Stock
- Ovintiv Announces Conference Call for Q3 Results in 2024
- Understanding the Recent Challenges Facing PNST Stock
- Opportunity Finance Network Launches Historic Climate Initiative
- BMO Reiterates Positive Outlook on Sandstorm Gold Investments
- Kevin Condardo Joins The Second City as New Managing Director
- Horizon Tech Finance Faces 52-Week Low: What Investors Should Know
- Revolutionary Boxing Gloves Designed for Enhanced Hand Protection
- Piper Sandler Optimistic About Tesla's Future Growth Potential
- PainReform (PRFX) Experiences 52-Week Low with Recovery Plans
- How US Consumers are Maintaining Strength Amid Economic Concerns
- Richardson Electronics Sees Mixed Q1 Performance but Optimism Soars
- Tilray Brands Achieves Exceptional Performance in Q1 2025
- Theratechnologies Delivers Strong Q3 Results and Growth Plans
- Aritzia Sees Revenue Surge in Q2 Amid U.S. Expansion
- Thunderbird Entertainment Sees Robust Q4 Growth and Profit
- Richelieu Hardware Reports Q3 Sales Growth Despite Market Challenges
- Educational Development Corp Faces Q2 Challenges Amid Losses
- T2 Biosystems Achieves Significant Revenue Growth and Partnerships
- Banking Giants Eye Bright Future as Earnings Rise
- Recent Developments for SoFi Technologies and Its Stock Value
- Czech Senate Moves to Regulate Kratom and HHC Product Sales
- Clover Health Growth: Star Ratings And Stock Performance Insights
- Teamsters Mobilize for Improved Contracts with United Airlines
- Shell plc's Strategic Share Buyback Plan Unveiled
- Hemlo Explorers Expands Private Placement to Meet Demand
- GSK Reaches Major Settlements Over Zantac Lawsuits, Future Uncertain
- Aetna Expands Services for Dual Eligible Medicare Beneficiaries
- Teva Pharmaceuticals Settles Major Kickback Allegations for $450M